348 results
Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention
09 Jul 2019
Results of the SMART-CHOICE randomized clinical trial
Reviewer
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI
09 Jul 2019
Results of the STOPDAPT-2 randomized clinical trial
Reviewer
Which interventional strategy is best for diabetic patients?
Which is the best revascularisation procedure to use in diabetic patients? Join Marco Valgimigli, Rafael Romaguera and Rosli Mohd Ali as they discuss the challenges of performing percutaneous coronary intervention (PCI) in everyday clinical practice in these patients. The integration of functional assessment of intermediate lesions, intravascular...
Magnetic resonance perfusion or fractional flow reserve in coronary disease
04 Jul 2019
The MR-INFORM study sought to compare the outcomes of a cardiovascular MRI-based strategy to an FFR-based strategy for guiding revascularisation in anginal patients.
Reviewer
Hope for improved PCI outcomes in diabetic patients with the Abluminus stent
Although huge progress has been made over the last four decades in percutaneous coronary intervention, the results in diabetic patients are still suboptimal, with higher rates of restenosis, target lesion revascularisation, vessel failures and mortality. Luca Testa, Roxana Mehran and Ashok Seth discuss the problems that...
Do we need new options in coronary physiology?
Which physiological index do you use? Watch Morton Kern of UC Irvine, Javier Escaned of Clinico Hospital San Carlos, and Jonathan Hill of King’s College discuss the need for new options in coronary physiology and why pressure guidewire performance matters.
This interview supported by Boston Scientific was...
What every interventional cardiologist should know about new cardiovascular drugs
Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...
Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease
03 Jun 2019
Reviewer
Reviewer
Highlights of EuroPCR 2019 - PCR's Got Talent winner
03 Jun 2019 – From EuroPCR 2019
Since its creation, PCR's Got Talent has riveted the attention of young investigators worldwide! Join EuroPCR Course Director William WIJNS as he speaks with 2017 winner Nina Van der Hoeven from the Netherlands discussing how the competition helped her improve her presentation skills, slides and communication...
Quality in the Cathlab: What is needed to establish a quality program (NAP)
Lynne Hinterbuchner, from the Salzburg University Clinic in Austria asks David Sparv, the Chief Nursing Officer for 5 hospitals in Sweden about quality in the Cathlab. Education and training for Cathlab nurses and allied professionals needs to be standardised. The European core curriculum leading to certification...
